| Testosterone | Approved Investigational | SLC6A5 | 9152 |
upregulated | testosterone undecanoate results in increased expression of SLC6A5 mRNA | 11p15.1 | |
| Testosterone | Approved Investigational | SRGN | 5552 |
downregulated | testosterone undecanoate results in decreased expression of SRGN mRNA | 10q22.1 | |
| Testosterone | Approved Investigational | SRP68 | 6730 |
upregulated | testosterone undecanoate results in increased expression of SRP68 mRNA | 17q25.1 | |
| Testosterone | Approved Investigational | STXBP5L | 9515 |
upregulated | testosterone undecanoate results in increased expression of STXBP5L mRNA | 3q13.33 | |
| Testosterone | Approved Investigational | TFDP2 | 7029 |
downregulated | testosterone undecanoate results in decreased expression of TFDP2 mRNA | 3q23 | |
| Testosterone | Approved Investigational | THPO | 7066 |
upregulated | testosterone undecanoate results in increased expression of THPO mRNA | 3q27.1 | |
| Testosterone | Approved Investigational | TMEM35A | 59353 |
downregulated | testosterone undecanoate results in decreased expression of TMEM35A mRNA | Xq22.1 | |
| Testosterone | Approved Investigational | TRA2A | 29896 |
downregulated | testosterone undecanoate results in decreased expression of TRA2A mRNA | 7p15.3 | |
| Testosterone | Approved Investigational | TTTY2 | 60439 |
upregulated | testosterone undecanoate results in increased expression of TTTY2 mRNA | Yp11.2 | |
| Testosterone | Approved Investigational | TUBB2A | 7280 |
upregulated | testosterone undecanoate results in increased expression of TUBB2A mRNA | 6p25.2 | |
| Testosterone | Approved Investigational | UNC13C | 440279 |
upregulated | testosterone undecanoate results in increased expression of UNC13C mRNA | 15q21.3 | |
| Testosterone | Approved Investigational | XIAP | 331 |
downregulated | testosterone undecanoate results in decreased expression of XIAP mRNA | Xq25 | |
| Testosterone | Approved Investigational | ZNF230 | 7773 |
upregulated | testosterone undecanoate results in increased expression of ZNF230 mRNA | 19q13.31 | |
| Tetracycline | Approved Investigational Vet Approved Withdrawn | AP1S1 | 1174 |
downregulated | Tetracycline results in decreased expression of AP1S1 mRNA | 7q22.1 | |
| Tetracycline | Approved Investigational Vet Approved Withdrawn | ASNS | 440 |
upregulated | Tetracycline results in increased expression of ASNS mRNA | 7q21.3 | |
| Tetracycline | Approved Investigational Vet Approved Withdrawn | CYP3A4 | 1576 |
upregulated | Tetracycline results in increased expression of CYP3A4 mRNA | 7q22.1 | |
| Tetracycline | Approved Investigational Vet Approved Withdrawn | EHHADH | 1962 |
downregulated | Tetracycline results in decreased expression of EHHADH mRNA | 3q27.2 | |
| Tetracycline | Approved Investigational Vet Approved Withdrawn | FNDC4 | 64838 |
upregulated | Tetracycline results in increased expression of FNDC4 mRNA | 2p23.3 | |
| Tetracycline | Approved Investigational Vet Approved Withdrawn | IGFBP1 | 3484 |
upregulated | Tetracycline results in increased expression of IGFBP1 mRNA | 7p12.3 | |
| Tetracycline | Approved Investigational Vet Approved Withdrawn | INHBE | 83729 |
upregulated | Tetracycline results in increased expression of INHBE mRNA | 12q13.3 | |
| Tetracycline | Approved Investigational Vet Approved Withdrawn | MTTP | 4547 |
downregulated | Tetracycline results in decreased expression of MTTP mRNA | 4q23 | |
| Tetracycline | Approved Investigational Vet Approved Withdrawn | NUPR1 | 26471 |
upregulated | Tetracycline results in increased expression of NUPR1 mRNA | 16p11.2 | |
| Tetracycline | Approved Investigational Vet Approved Withdrawn | SERPINA3 | 12 |
upregulated | Tetracycline results in increased expression of SERPINA3 mRNA | 14q32.13 | |
| Tetracycline | Approved Investigational Vet Approved Withdrawn | SREBF1 | 6720 |
upregulated | Tetracycline results in increased expression of SREBF1 mRNA | 17p11.2 | |
| Tetracycline | Approved Investigational Vet Approved Withdrawn | TAGLN | 6876 |
downregulated | Tetracycline results in decreased expression of TAGLN mRNA | 11q23.2 | |